LEANBH study: Device satisfaction study for the use of a novel connected home blood pressure system in pregnancy; a prospective cohort study.

Publication date: Jan 28, 2025

To investigate patients’ perspectives on using the LEANBH app (home Blood Pressure BP monitoring system) and the Microlife Watch BP home monitor in a tertiary maternity hospital setting during the COVID-19 pandemic. 134 Participants were asked to complete an anonymous usability questionnaire on their experience of LEANBH and the Microlife Watch. The questionnaire consisted of 5 background demographics, 9 items from the system usability scale (SUS), 14 items on the usability of the LEANBH app, and 6 on the acceptability of Microlife. The usability questionnaire for the LEANABH app suggested 69% (93) of respondents reported a very good initial impression of the app, while 29% agreed and 70% strongly agreed that it was easy to use. The Microlife Watch was tolerated very well with 42% agreeing and 56% strongly agree they would use it again. Only 8 (6%) reported it to be an inconvenience to take their own BP at home. Nearly all users (97%) agreed that the knowledge their BP was being monitored at home gave them a sense of safety. Patients’ experience of the LEANBH app and Microlife Watch BP Home monitor were very reassuring and suggest it is an acceptable way of monitoring home BP in pregnant women who are at risk of rapid changes in health status. Women reported feeling a greater sense of health and safety with the use of this device. Further work remains to be done for the widespread validation and implementation of the LEANBH platform and application.

Concepts Keywords
Covid Ambulatory BP monitoring
Hospital Hypertension
Maternity Pregnancy
Pandemic
Satisfaction

Semantics

Type Source Name
disease IDO blood
disease MESH COVID-19 pandemic
disease MESH health status
disease MESH Hypertension

Original Article

(Visited 1 times, 1 visits today)